A first in man study of CAR-T CD44v6.

Trial Profile

A first in man study of CAR-T CD44v6.

Phase of Trial: Phase I

Latest Information Update: 19 Mar 2018

At a glance

  • Drugs CAR-CD44v6 (Primary)
  • Indications Haematological malignancies; Solid tumours
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 19 Mar 2018 New trial record
    • 09 Mar 2018 According to a MolMed media release, company plans to initiate the first in man study in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top